Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors.
about
Should we be combining local tumor therapies with immunotherapies as standard?Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model.Current status and perspectives in immunotherapy for metastatic melanoma.Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.Activation of viral defense signaling in cancer
P2860
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Combining talimogene laherpare ...... lanoma and other solid tumors.
@en
type
label
Combining talimogene laherpare ...... lanoma and other solid tumors.
@en
prefLabel
Combining talimogene laherpare ...... lanoma and other solid tumors.
@en
P2093
P2860
P921
P1476
Combining talimogene laherpare ...... lanoma and other solid tumors.
@en
P2093
Christoph Hoeller
Isabella Pezzani Gruter
Olivier Michielin
Reinhard Dummer
P2860
P2888
P304
P356
10.1007/S00262-017-1967-1
P5008
P577
2017-02-25T00:00:00Z
2017-06-01T00:00:00Z
P6179
1083914061